middle.news
TrivarX Builds the Runway for Stabl-Im Human Testing
9:36am on Wednesday 23rd of September, 2026 AEST
•
Healthcare Technology
Read Story
TrivarX Builds the Runway for Stabl-Im Human Testing
9:36am on Wednesday 23rd of September, 2026 AEST
Key Points
Pre-clinical studies have commenced, with completion targeted for November 2026
Clinical site and Principal Investigator selection is underway
Specialist deuterium analysis methodology is being developed for study samples
Ethics submission is planned for Q4 CY26, with first enrolment targeted for Q1 CY27
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Trivarx (ASX:TRI)
OPEN ARTICLE